Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Fox

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Pathology|November 1, 2019
Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancerNick Pavlakis, Caroline Cooper, Thomas John, et al.
Familial Cancer|February 14, 2015
Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk featuresPaul A James, Sarah Sawyer, Samantha Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study GroupKathryn Alsop, Sian Fereday, Cliff Meldrum, et al.
Oncoimmunology|September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerRosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
The Journal of Pathology|September 17, 2013
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primaryRichard W Tothill, Jason Li, Linda Mileshkin, et al.
Oncotarget|December 15, 2018
Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphomaPiers Blombery, Ella Thompson, Georgina L Ryland, et al.
The American Journal of Surgical Pathology|April 4, 2025
Molecular Analysis of Cutaneous Sarcomatoid Neoplasms Frequently Identifies Melanoma Driver VariantsLouise A Jackett, Catherine Mitchell, Cameron Snell, et al.
British Journal of Cancer|May 24, 2023
Six-year experience of Australia's first dedicated cancer of unknown primary clinicArielle van Mourik, Gina Tonkin-Hill, John O'Farrell, et al.
Histopathology|July 20, 2024
Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastClarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, et al.
Oncotarget|November 28, 2014
Role of p53 in the progression of gastric cancerRita A Busuttil, Giada V Zapparoli, Sue Haupt, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Pathology|November 1, 2019
Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancerNick Pavlakis, Caroline Cooper, Thomas John, et al.
Familial Cancer|February 14, 2015
Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk featuresPaul A James, Sarah Sawyer, Samantha Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study GroupKathryn Alsop, Sian Fereday, Cliff Meldrum, et al.
Oncoimmunology|September 14, 2016
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancerRosemary Millen, Jordane Malaterre, Ryan S Cross, et al.
The Journal of Pathology|September 17, 2013
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primaryRichard W Tothill, Jason Li, Linda Mileshkin, et al.
Oncotarget|December 15, 2018
Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphomaPiers Blombery, Ella Thompson, Georgina L Ryland, et al.
The American Journal of Surgical Pathology|April 4, 2025
Molecular Analysis of Cutaneous Sarcomatoid Neoplasms Frequently Identifies Melanoma Driver VariantsLouise A Jackett, Catherine Mitchell, Cameron Snell, et al.
British Journal of Cancer|May 24, 2023
Six-year experience of Australia's first dedicated cancer of unknown primary clinicArielle van Mourik, Gina Tonkin-Hill, John O'Farrell, et al.
Histopathology|July 20, 2024
Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastClarissa Jing Wen Wong, Nur Diyana Md Nasir, Valerie Cui Yun Koh, et al.
Oncotarget|November 28, 2014
Role of p53 in the progression of gastric cancerRita A Busuttil, Giada V Zapparoli, Sue Haupt, et al.
Pageof 12